A worker packs Sinovac/VACSERA coronavirus vaccine vials in Egypt. Egyptian Ministry of Health
A delegation of technical experts from EuroHealthNet are on a visit to Cairo from 31 January and 3 February to learn about Egypt’s production capacity, the foreign ministry said in a statement on Wednesday.
The Belgium-based EuroHealthNet is a non-profit partnership of organisations and bodies that works on promoting health and health equity.
This first exploratory visit of its kind seeks to determine the production requirements for vaccine manufacturing in Egypt, the ministry said.
The visit aims to formulate the best cooperation frameworks between the two sides for vaccine production in Egypt to meet local needs and export vaccine doses to African countries, according to the statement.
The visit also comes as part of the European Union’s initiative to allocate 1 billion euros for a program that seeks to build vaccine manufacturing hubs in African countries in a way that contributes to achieving self-sufficiency in vaccine supplies in the continent, the ministry said.
Egypt has manufactured millions of doses of Sinovac’s coronavirus vaccine as per agreements signed with the Chinese company in April last year. The country aims to produce 60 million Sinovac vaccine doses per year.
Egyptian officials have also revealed intentions last year to locally produce the American Moderna and Russia’s Sputnik V vaccines.
Ambassador Ihab Nasr, the assistant foreign minister on European affairs, chaired the Tuesday meeting. Officials from the Egyptian ministries of health, trade and industry, higher education and scientific research, and international cooperation attended the meeting.
The meeting was also attended by officials from the Egyptian Drug Authority, the Holding Company for Biological Products and Vaccines, and the Egyptian Authority for Unified Procurement, Medical Supply and the Management of Medical Technology.